SCHEMBL16845264

SCHEMBL16845264

BCCCC[C@H]1C=CC=CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18295756 0.79 SIGMAR1 (0.33) SIGMAR1
SCHEMBL30695179 0.79 ALDH1A1 (0.39) SIGMAR1
SCHEMBL18951468 0.78 SIGMAR1 (0.35) SIGMAR1
SCHEMBL29465826 0.78 LMNA (0.31) SIGMAR1
SCHEMBL3439756 0.77 SIGMAR1 (0.31) SIGMAR1
SCHEMBL13957201 0.77 SIGMAR1 (0.31) SIGMAR1
SCHEMBL13892566 0.75
SCHEMBL28413863 0.75 TSHR (0.34)
SCHEMBL2173048 0.75 SIGMAR1 (0.31) SIGMAR1
SCHEMBL9286912 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2886530-A1 ORALLY ADMINISTRABLE VIRIDIOFUNGIN DERIVATIVE HAVING ANTI-HCV ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 2015-06-24 EP disclosed